Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL9442079 | 0.96 | CA5A (0.50) | — | |
| Sulfuric Acid SCHEMBL17556243 | 0.87 | — | — | |
| Sulfuric Acid SCHEMBL8528930 | 0.84 | — | — | |
| Sulfuric Acid SCHEMBL27990208 | 0.84 | — | — | |
| Thiosulfuric Acid SCHEMBL28790193 | 0.84 | — | — | |
| Thiosulfuric Acid SCHEMBL28790194 | 0.84 | — | — | |
| SCHEMBL27504039 | 0.84 | — | — | |
| SCHEMBL6521836 | 0.78 | — | — | |
| Sulfuric Acid SCHEMBL21051143 | 0.78 | CA5A (0.50) | — | |
| SCHEMBL620005 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108395444-B | Preparation method of 3-ethyl cefadroxil | 梯尔希（南京）药物研发有限公司 | 2020-06-12 | — | — | CN | claimed |
| CN-108395444-A | A kind of preparation method of 3- ethyls cefadroxil | 梯尔希（南京）药物研发有限公司 | 2018-08-14 | — | — | CN | claimed |
| CN-220633012-U | Efficient and energy-saving sulfuric acid evaporation concentration system | 贵州兰鑫石墨机电设备制造有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117018646-A | Efficient and energy-saving sulfuric acid evaporation concentration system and process | 贵州兰鑫石墨机电设备制造有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-109665499-B | Waste sulfuric acid heat accumulating type incineration SO preparation 2 Process gas technology and system | 大连科汇工程技术有限公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-108395444-B | Preparation method of 3-ethyl cefadroxil | 梯尔希（南京）药物研发有限公司 | 2020-06-12 | — | — | CN | disclosed |
| CN-108395444-A | A kind of preparation method of 3- ethyls cefadroxil | 梯尔希（南京）药物研发有限公司 | 2018-08-14 | — | — | CN | disclosed |
| CN-108238851-A | Antioxidant 2, the process units of 6- di-tert-butyl-4-methy phenols | 成都韦恩斯科技有限公司 | 2018-07-03 | — | — | CN | disclosed |
| US-6740760-B2 | SUCH AS 1-((S)-3-MERCAPTO-2-METHYL-PROPIONYL)-(R)-PYRROL-IDINE-2-CARBOXYLIC ACID FOR TREATING DISEASES ASSOCIATED WITH AMYLOIDOSIS (ALZHEIMER'S DISEASE, DIABETES, AND FAMILIAL AMYLOID POLYNEUROPATHY) | HOFFMANN-LA ROCHE INC. | 2004-05-25 | — | — | US | disclosed |
| US-20030100770-A1 | Such as 1-((S)-3-mercapto-2-methyl-propionyl)-(R)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (Alzheimer's disease, diabetes, and familial amyloid polyneuropathy) | PENTRAXIN THERAPEUTICS LTD. (GB) | 2003-05-29 | — | — | US | disclosed |
| US-6512001-B1 | To treat diseases associated with amyloidosis, such as Alzheimer's disease | HOFFMANN-LA ROCHE INC. | 2003-01-28 | — | — | US | disclosed |
| EP-0915088-B1 | D-Proline derivatives | HOFFMANN LA ROCHE (CH) | 2002-09-18 | — | — | EP | disclosed |
| US-6262089-B1 | USING THESE COMPOUNDS TO TREAT DISEASES ASSOCIATED WITH AMYLOIDOSIS, SUCH AS ALZHEIMER'S DISEASE, MATURITY ONSET DIABETES MELLITUS, FAMILIAL AMYLOID POLYNEUROPATHY, SCRAPIE, AND KREUZFELD-JACOB DISEASE. | HOFFMAN-LA ROCHE INC. | 2001-07-17 | — | — | US | disclosed |
| EP-0915088-A1 | D-Proline derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1999-05-12 | — | — | EP | disclosed |
| CN-1026979-C | One-step synthesis of tert-butyl threonine | UNIV JILIN (CN) | 1994-12-14 | — | — | CN | disclosed |